Difficulty: Medium
Average Score: 80%
Practice
An elderly man, in obvious respiratory distress due to exacerbation of his emphysema and chronic bronchitis, presents in the emergency department. One drug ordered by the physician, to be administered by respiratory therapist, is $N$-acetylcysteine. Which of the following is main action or purpose of this drug?
Correct answer
D
Rationale
The correct answer is D) Thin airway mucus secretions for easier removal by suctioning or postural drainage.
$N$-acetylcysteine is a mucolytic agent commonly used to help liquefy and loosen thick mucus in conditions like chronic bronchitis and emphysema. By thinning the airway mucus secretions, it makes it easier for the patient to cough up and clear the mucus, thus improving ventilation and reducing the risk of respiratory complications.
Option A) Block receptors for the cysteinyl leukotrienes is incorrect as this action is typically associated with leukotriene receptor antagonists, not $N$-acetylcysteine.
Option B) Inhibit metabolic inactivation of epinephrine or $B_2$-agonists that were administered is incorrect as this action is not a known pharmacological effect of $N$-acetylcysteine.
Option C) Inhibit leukotriene synthesis is incorrect as this action is associated with drugs like leukotriene synthesis inhibitors, not $N$-acetylcysteine.
Educationally, understanding the mechanism of action of respiratory drugs like $N$-acetylcysteine is crucial for healthcare professionals to provide appropriate and effective care for patients with respiratory conditions. Knowing how different drugs work allows for tailored treatment plans based on the specific needs of each patient.
$N$-acetylcysteine is a mucolytic agent commonly used to help liquefy and loosen thick mucus in conditions like chronic bronchitis and emphysema. By thinning the airway mucus secretions, it makes it easier for the patient to cough up and clear the mucus, thus improving ventilation and reducing the risk of respiratory complications.
Option A) Block receptors for the cysteinyl leukotrienes is incorrect as this action is typically associated with leukotriene receptor antagonists, not $N$-acetylcysteine.
Option B) Inhibit metabolic inactivation of epinephrine or $B_2$-agonists that were administered is incorrect as this action is not a known pharmacological effect of $N$-acetylcysteine.
Option C) Inhibit leukotriene synthesis is incorrect as this action is associated with drugs like leukotriene synthesis inhibitors, not $N$-acetylcysteine.
Educationally, understanding the mechanism of action of respiratory drugs like $N$-acetylcysteine is crucial for healthcare professionals to provide appropriate and effective care for patients with respiratory conditions. Knowing how different drugs work allows for tailored treatment plans based on the specific needs of each patient.